Skip to main content

Detailed Information

  • November 17, 2024
    8:00am - 12:00pm
    Type: Short Course
    Capacity: 108


    Participants will see the principles of what makes RWE decision-grade. We will review the most recent RWE frameworks and guidelines and examine case studies where RWE was used in regulatory and HTA approval. We will introduce an extended example where participants will examine an indication expansion study and discuss how key choices made may affect the meaning and interpretability of results.


    ...

ISPOR–The Professional Society for 
Health Economics and Outcomes Research

 

Copyright © 2026 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc